Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers.

Cathcart-Rake E, O'Connor JM, Ridgeway JL, Breitkopf CR, Guire LJM, Olson EA, Kaur JS, Leventakos K, Jatoi A.

Am J Hosp Palliat Care. 2019 Oct 10:1049909119879129. doi: 10.1177/1049909119879129. [Epub ahead of print]

PMID:
31601116
2.

Disparities in Cancer Incidence and Trends among American Indians and Alaska Natives in the United States, 2010-2015.

Melkonian SC, Jim MA, Haverkamp D, Wiggins CL, McCollum J, White MC, Kaur JS, Espey DK.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1604-1611. doi: 10.1158/1055-9965.EPI-19-0288.

PMID:
31575554
3.

Improving Research Literacy in Diverse Minority Populations with a Novel Communication Tool.

Simon MA, Haring R, Rodriguez EM, González E, Kaur JS, Kirschner M, Tom L, O'Brian CA, Katz ML.

J Cancer Educ. 2019 Dec;34(6):1120-1129. doi: 10.1007/s13187-018-1418-5.

PMID:
30144005
4.

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance).

Vera Aguilera J, Rao RD, Allred JB, Suman VJ, Windschitl HE, Kaur JS, Maples WJ, Lowe VJ, Creagan ET, Erickson LA, Markovic S.

Oncologist. 2018 Aug;23(8):887-e94. doi: 10.1634/theoncologist.2018-0100. Epub 2018 Apr 17.

5.

How can an Education Workshop Serve as an Intervention for American Indian Screening Participation.

Burhansstipanov L, Harjo L, Kaur JS.

J Cancer Educ. 2019 Apr;34(2):216-222. doi: 10.1007/s13187-017-1289-1.

PMID:
29159787
6.

Alcohol and Cancer: A Statement of the American Society of Clinical Oncology.

LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ.

J Clin Oncol. 2018 Jan 1;36(1):83-93. doi: 10.1200/JCO.2017.76.1155. Epub 2017 Nov 7.

PMID:
29112463
7.

Findings from American Indian Needs Assessments.

Burhansstipanov L, Krebs LU, Harjo L, Ragan K, Kaur JS, Marsh V, Painter D Sr.

J Cancer Educ. 2018 Jun;33(3):576-582. doi: 10.1007/s13187-016-1159-2.

PMID:
28214933
8.

Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients.

Sloan JA, Liu H, Satele DV, Puttabasavaiah S, Kaur JS, Hubbard J, Dueck A, Stella PJ, Singh JA.

Trends Cancer Res. 2017;12:97-110.

9.

The experience of treatment barriers and their influence on quality of life in American Indian/Alaska Native breast cancer survivors.

Goodwin EA, Burhansstipanov L, Dignan M, Jones KL, Kaur JS.

Cancer. 2017 Mar 1;123(5):861-868. doi: 10.1002/cncr.30406. Epub 2016 Oct 20.

10.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR.

N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5.

11.

QOL and Survival Comparisons by Race in Oncology Clinical Trials.

Tan AD, Novotny PJ, Kaur JS, Buckner JC, Mowat RB, Paskett E, Sloan JA.

J Cancer Clin Oncol. 2016 Mar-Aug;2(1). pii: 100112. Epub 2016 Nov 16.

12.

Lessons Learned from Native C.I.R.C.L.E., a Culturally Specific Resource.

Garcia A, Baethke L, Kaur JS.

J Cancer Educ. 2017 Dec;32(4):740-744. doi: 10.1007/s13187-016-1001-x.

PMID:
26911858
13.

Gastrointestinal Metastases from Breast Cancer, a Comprehensive Review.

Wiisanen JM, Kaur JS.

Breast J. 2015 Sep-Oct;21(5):572-3. doi: 10.1111/tbj.12464. Epub 2015 Jul 28. Review. No abstract available.

PMID:
26215570
14.

How should we "empower" cancer patients?

Kaur JS.

Cancer. 2014 Oct 15;120(20):3108-10. doi: 10.1002/cncr.28852. Epub 2014 Jul 2. No abstract available.

15.

Ovarian and uterine cancer incidence and mortality in American Indian and Alaska Native women, United States, 1999-2009.

Singh SD, Ryerson AB, Wu M, Kaur JS.

Am J Public Health. 2014 Jun;104 Suppl 3:S423-31. doi: 10.2105/AJPH.2013.301781. Epub 2014 Apr 22.

16.

Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States.

White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS.

Am J Public Health. 2014 Jun;104 Suppl 3:S377-87. doi: 10.2105/AJPH.2013.301673. Epub 2014 Apr 22.

17.

Breast cancer mortality among American Indian and Alaska Native women, 1990-2009.

White A, Richardson LC, Li C, Ekwueme DU, Kaur JS.

Am J Public Health. 2014 Jun;104 Suppl 3:S432-8. doi: 10.2105/AJPH.2013.301720. Epub 2014 Apr 22. Erratum in: Am J Public Health. 2014 Aug;104(8):e6.

18.

Regional differences in breast cancer biomarkers in american Indian and Alaska native women.

Kaur JS, Vierkant RA, Hobday T, Visscher D.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):409-15. doi: 10.1158/1055-9965.EPI-13-0738.

19.

Rare presentations of primary melanoma and special populations: a systematic review.

Kottschade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, Jakub JW, Bagaria SP, Kumar R, Kaur JS, Morita SY, Moran SL, Nguyen JT, Nguyen EC, Hand JL, Erickson LA, Brewer JD, Baum CL, Miller RC, Swanson DL, Lowe V, Markovic SN.

Am J Clin Oncol. 2014 Dec;37(6):635-41. doi: 10.1097/COC.0b013e3182868e82. Review.

20.

Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.

Dronca RS, Allred JB, Perez DG, Nevala WK, Lieser EA, Thompson M, Maples WJ, Creagan ET, Pockaj BA, Kaur JS, Moore TD, Marchello BT, Markovic SN.

Am J Clin Oncol. 2014 Aug;37(4):369-76. doi: 10.1097/COC.0b013e31827b45d4.

21.

Successful implementation of a telemedicine-based counseling program for high-risk patients with breast cancer.

Pruthi S, Stange KJ, Malagrino GD Jr, Chawla KS, LaRusso NF, Kaur JS.

Mayo Clin Proc. 2013 Jan;88(1):68-73. doi: 10.1016/j.mayocp.2012.10.015.

PMID:
23274020
22.
23.

A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.

Kottschade LA, Suman VJ, Perez DG, McWilliams RR, Kaur JS, Amatruda TT 3rd, Geoffroy FJ, Gross HM, Cohen PA, Jaslowski AJ, Kosel ML, Markovic SN.

Cancer. 2013 Feb 1;119(3):586-92. doi: 10.1002/cncr.27760. Epub 2012 Aug 22.

24.

Enhancing life after cancer in diverse communities.

Kaur JS, Coe K, Rowland J, Braun KL, Conde FA, Burhansstipanov L, Heiney S, Kagawa-Singer M, Lu Q, Witte C.

Cancer. 2012 Nov 1;118(21):5366-73. doi: 10.1002/cncr.27491. Epub 2012 Mar 20.

25.

Personalized medicine: challenge and promise.

Kaur JS, Petereit DG.

J Cancer Educ. 2012 Apr;27(1 Suppl):S12-7. doi: 10.1007/s13187-012-0322-7.

26.

Introduction to SOE Special Issue.

Kaur JS, Wiggins C, Burhansstipanov L.

J Cancer Educ. 2012 Apr;27(1 Suppl):S1-3. doi: 10.1007/s13187-012-0321-8. No abstract available.

PMID:
22322864
27.

Comparison of quality of life between Native and non-Native cancer survivors: Native and non-Native cancer survivors' QOL.

Burhansstipanov L, Dignan M, Jones KL, Krebs LU, Marchionda P, Kaur JS.

J Cancer Educ. 2012 Apr;27(1 Suppl):S106-13. doi: 10.1007/s13187-012-0318-3.

28.

Fluctuation of systemic immunity in melanoma and implications for timing of therapy.

Leontovich AA, Dronca RS, Suman VJ, Ashdown ML, Nevala WK, Thompson MA, Robinson A, Kottschade LA, Kaur JS, McWilliams RR, Ivanov LV, Croghan GA, Markovic SN.

Front Biosci (Elite Ed). 2012 Jan 1;4:958-75.

PMID:
22201928
29.

Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.

Block MS, Suman VJ, Nevala WK, Kottschade LA, Creagan ET, Kaur JS, Quevedo JF, McWilliams RR, Markovic SN.

Melanoma Res. 2011 Oct;21(5):438-45. doi: 10.1097/CMR.0b013e32834640c0.

PMID:
21697748
30.

What a difference one person can make: a tribute to Mary P. Lovato.

Burhansstipanov L, O'Donnell J, Paisano R, Krebs LU, Kaur JS, Hill TA, Lovato MP.

J Cancer Educ. 2011 Sep;26(3):591-3. doi: 10.1007/s13187-011-0236-9. No abstract available.

PMID:
21681435
31.

Palliative care consultations in patients with cancer: a mayo clinic 5-year review.

Kamal AH, Swetz KM, Carey EC, Cheville AL, Liu H, Ruegg SR, Moynihan TJ, Sloan JA, Kaur JS.

J Oncol Pract. 2011 Jan;7(1):48-53. doi: 10.1200/JOP.2010.000067.

32.

Safe use of opioids to manage pain in patients with cirrhosis.

Swetz KM, Carey EC, Rho RH, Mauck WD, Whitford KJ, Moynihan TJ, Kaur JS, Coyne PJ, Smith TJ.

Mayo Clin Proc. 2010 Oct;85(10):959; author reply 960. doi: 10.4065/mcp.2010.0294. No abstract available.

33.

Adaptation, dissemination, and evaluation of a cancer palliative care curriculum for the Indian health system.

Arenella C, Finke B, Domer T, Kaur JS, Merriman MP, Ousley A.

J Palliat Care. 2010 Spring;26(1):15-21.

PMID:
20402180
34.

Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy.

Larson BR, Looker S, Herrera DM, Creagan ET, Hayman SR, Kaur JS, Jatoi A.

J Cancer Educ. 2010 Sep;25(3):396-400. doi: 10.1007/s13187-010-0062-5. Epub 2010 Feb 24.

35.

Native American breast cancer survivors' physical conditions and quality of life.

Burhansstipanov L, Krebs LU, Seals BF, Bradley AA, Kaur JS, Iron P, Dignan MB, Thiel C, Gamito E.

Cancer. 2010 Mar 15;116(6):1560-71. doi: 10.1002/cncr.24924.

36.

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ.

Cancer Res. 2010 Feb 1;70(3):875-82. doi: 10.1158/0008-5472.CAN-09-2762. Epub 2010 Jan 26.

37.

The impact of multi-modal therapy on survival for uterine carcinosarcomas.

Gonzalez Bosquet J, Terstriep SA, Cliby WA, Brown-Jones M, Kaur JS, Podratz KC, Keeney GL.

Gynecol Oncol. 2010 Mar;116(3):419-23. doi: 10.1016/j.ygyno.2009.10.053. Epub 2009 Nov 5.

PMID:
19896181
38.

The erosive potential of some alcopops using bovine enamel: an in vitro study.

Ablal MA, Kaur JS, Cooper L, Jarad FD, Milosevic A, Higham SM, Preston AJ.

J Dent. 2009 Nov;37(11):835-9. doi: 10.1016/j.jdent.2009.06.016. Epub 2009 Jun 30.

PMID:
19616357
39.

Lessons learned from a community-based participatory research project to improve American Indian cancer surveillance.

Matloub J, Creswell PD, Strickland R, Pierce K, Stephenson L, Waukau J, Kaur JS, Remington P.

Prog Community Health Partnersh. 2009 Spring;3(1):47-52. doi: 10.1353/cpr.0.0058.

PMID:
20208301
40.

Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004.

Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, Jackson-Thompson J, Arambula Solomon TG.

Cancer. 2008 Sep 1;113(5 Suppl):1191-202. doi: 10.1002/cncr.23725.

41.

Cancer among American Indians and Alaska Natives in the United States, 1999-2004.

Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J, Miller BA, Jim MA, Kelly JJ, Lanier AP.

Cancer. 2008 Sep 1;113(5 Suppl):1142-52. doi: 10.1002/cncr.23734.

42.

Cancer in American Indian and Alaska Native populations continues to threaten an aging population : the need for tribal, state, and federal action.

Kaur JS, Hampton JW.

Cancer. 2008 Sep 1;113(5 Suppl):1117-9. doi: 10.1002/cncr.23730. No abstract available.

43.

Palliative practice in Indian health.

Domer T, Kaur JS.

S D Med. 2008;Spec No.:36-40.

PMID:
18642617
44.

Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions.

McKean H, Looker S, Hartmann LC, Hayman SR, Kaur JS, McWilliams RR, Peethambaram PP, Stahl JF, Jatoi A.

J Nutr Educ Behav. 2008 May-Jun;40(3):144-8. doi: 10.1016/j.jneb.2007.08.009.

PMID:
18457782
45.

Response of cutaneous metastases from breast cancer to capecitabine.

Sideras K, Zahasky KM, Kaur JS.

Clin Med Oncol. 2008;2:415-8. Epub 2008 Apr 18. No abstract available.

46.

Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participation.

Patten CA, Enoch C, Renner CC, Offord KP, Nevak C, Kelley SF, Thomas J, Decker PA, Hurt RD, Lanier A, Kaur JS.

Health Educ Behav. 2009 Aug;36(4):711-23. Epub 2007 Nov 29.

47.

Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives.

Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA, Howe HL, Ries LA, Miller BA, Jemal A, Ahmed F, Cobb N, Kaur JS, Edwards BK.

Cancer. 2007 Nov 15;110(10):2119-52.

48.

Cancer health effects of pesticides: systematic review.

Bassil KL, Vakil C, Sanborn M, Cole DC, Kaur JS, Kerr KJ.

Can Fam Physician. 2007 Oct;53(10):1704-11. Review.

49.

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.

Markovic SN, Suman VJ, Rao RA, Ingle JN, Kaur JS, Erickson LA, Pitot HC, Croghan GA, McWilliams RR, Merchan J, Kottschade LA, Nevala WK, Uhl CB, Allred J, Creagan ET.

Am J Clin Oncol. 2007 Jun;30(3):303-9.

PMID:
17551310
50.

The "Spirit of Eagles" legacy.

Kaur JS, Dignan M, Burhansstipanov L, Baukol P, Claus C.

Cancer. 2006 Oct 15;107(8 Suppl):1987-94.

Supplemental Content

Support Center